Objective: To compare the effectiveness of needle aspiration and chest tube drainage in the management of primary spontaneous pneumothorax Subject and Methods: A Total of 58 patients of primary spontaneous pneumothorax PSP were divided into two groups as per management modality. Group A was treated with needle aspiration NA and group B was managed with chest tube drainage CTD. Frequency of gender and current smoker was noted. Mean and standard deviation was calculated for age and body mass index BMI. Clinical characteristics like hospitalization days, immediate and 1 week success rate and recurrence was noted on proforma. Frequency of minor postoperative complication was observed for both groups. Results: The majority of patients were males in both groups. Mean age of patients was 47.29 ± 5.68 for NA group and 49.28 ± 6.25 for CTD group. Immediate and 1 week success rate was 17 (58.6%) 27 (93.1%) for NA group, while in CTD group it was 22 (75.86%) and 28 (96.5%) respectively. Mean hospitalization time for NA group was 1.42±0.38, and for CTD it was 4.62±1.12. 1 year recurrence rate was higher in NA group than the CTD group. Conclusion: Considering its advantages, NA was recommended as first line management in the patients of PSP. Keywords: Needle Aspiration, Chest Tube Drainage, Primary, Spontaneous Pneumothorax, Hospitalization, Success, Recurrence.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.